Skip to main content
. 2020 Jul 29;155(9):861–868. doi: 10.1001/jamasurg.2020.2423

Table 2. Characteristics of Patients With Kidney Stones and Hypercalcemia Who Completed Parathyroid Hormone Level Measurement.

Characteristic No. (%) P value
Total patients (n = 1873) Hypercalcemia
Measured (n = 1369) Albumin-corrected (n = 504)
PTH level, median (IQR), pg/mL 67.7 (32.0-121.6) 71.8 (32.3-125.3) 58.7 (31.1-104.2) .09
Serum calcium concentration, median (IQR), mg/dL 10.8 (10.6-11.1) 10.9 (10.7-11.2) 10.7 (10.6-10.8) <.001
No. of calcium concentration measurements >10.5 mg/dL per patient, median (IQR) 2.0 (1.0-4.0) 2.0 (1.0-1.4) 1.0 (1.0-3.0) .58
Elevated PTH level 717 (38.3) 558 (40.8) 159 (31.5) <.001
24-h Urine calcium excretion, median (IQR), mg 206.0 (96.0-331.1) 221.0 (111.0-324.5) 104.5 (42.5-208.2) <.001
eGFR <45 mL/min/1.73 m2 804 (42.9) 493 (36.0) 311 (61.7) <.001
Parathyroidectomy
Within 2 y 189 (10.1) 185 (13.5) 4 (0.8) <.001
2-5 y 34 (1.8) 31 (2.3) 3 (0.6) .02

Abbreviations: eGFR, estimated glomerular filtration rate; IQR, interquartile range; PTH, parathyroid hormone.

SI conversion factors: To convert serum calcium concentration to millimoles per liter, multiply by 0.25; PTH to nanograms per liter, multiply by 1.